How to Buy syncomf Shares on Fincept?
You can buy Syncom Formulations (India) Limited shares on Different Brokers & Banks by creating an account and completing KYC verification online.
NSE: Syncom Formulations (India) Limited Share Price Today, Share Analysis, Latest Updates & Insights | Fincept
Stay informed with the latest announcements for Syncomf, including updates on board meetings and corporate actions.
Syncom Formulations (India) Limited - https://www.syncomformulations.com
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India. It operates through Manufacturing and Dealing in Pharmaceutical Drug & Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, gynae, opthal, ortho, and pediatrics formulations. It provides life care, evolve, and right nutrition products under the Cratus brand. In addition, the company engages in the trading of commodities and renting of properties. It also exports its products. The company offers its pharmaceutical formulations products in various dosage forms, such as tablets, capsules, ointments, injections, liquids orals, and effervescent. Syncom Formulations (India) Limited was incorporated in 1988 and is based in Indore, India.
Syncom Formulations (India) Limited Share Price Today
17.93
OPEN
17.99
HIGH
17.50
LOW
17.63
CLOSE
1,451 K
VOLUME
1,932 Cr
Market Cap
3928179
Average Volume
Healthcare
Sector
NSI
Exchange
Syncom Formulations (India) Limited Share Analysis & 2025 Insights
Investor Presentations
| Date | Description | Download |
|---|
SIP
Lumpsum
Invested Amount: ₹
Estimated Returns: ₹
Total Value: ₹
NSE: SYNCOMF Stock Actions
Company |
Symbol |
ISIN |
Subject |
Ex Date |
Face Value |
Broadcast Date |
|---|---|---|---|---|---|---|
Syncom Formulations (India) Limited |
SYNCOMF |
INE312C01025 |
Annual General Meeting |
23 Sep 2024 |
1 |
N/A |
Syncom Formulations (India) Limited |
SYNCOMF |
INE312C01025 |
Annual General Meeting |
18 Sep 2023 |
1 |
N/A |
NSE: SYNCOMF Recent Announcements
Symbol |
Date |
Description |
Industry |
|---|---|---|---|
SYNCOMF |
26 Dec 2024, 15:41:36 |
Trading Window-XBRL |
N/A |
SYNCOMF |
26 Dec 2024, 15:40:44 |
Trading Window |
N/A |
SYNCOMF |
19 Dec 2024, 16:48:05 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
SYNCOMF |
19 Dec 2024, 16:47:25 |
Loss of Share Certificates |
N/A |
SYNCOMF |
26 Nov 2024, 14:05:34 |
Loss/Duplicate-Share Certificate-XBRL |
N/A |
NSE: SYNCOMF Corporate Governance
Name |
Symbol |
Timestamp |
Submission Date |
XBRL Document |
|---|---|---|---|---|
Syncom Formulations (India) Limited |
SYNCOMF |
19 Oct 2024, 13:26:00 |
19 Oct 2024, 13:27:00 |
|
Syncom Formulations (India) Limited |
SYNCOMF |
19 Jul 2024, 18:39:00 |
19 Jul 2024, 18:40:00 |
|
Syncom Formulations (India) Limited |
SYNCOMF |
09 Aug 2024, 13:33:00 |
09 Aug 2024, 13:33:00 |
|
Syncom Formulations (India) Limited |
SYNCOMF |
13 Jan 2024, 20:45:00 |
13 Jan 2024, 21:15:00 |
|
Syncom Formulations (India) Limited |
SYNCOMF |
21 Oct 2023, 20:00:00 |
21 Oct 2023, 20:30:00 |
NSE: SYNCOMF Detailed Governance
Category |
Date of Birth |
Date of Initial Appointment |
DIN |
Director Name |
Status |
|---|---|---|---|---|---|
Chairperson & Executive Director |
25 Aug 1952 |
13 Apr 1992 |
00023050 |
Kedarmal Shankarlal Bankda |
Active |
Executive Director-MD |
17 Sep 1958 |
01 Dec 1999 |
00023027 |
Vijay Shankarlal Bankda |
Active |
Executive Director |
14 Jun 1987 |
13 Aug 2014 |
06946754 |
Rinki Ankit Bankda |
Active |
Independent Director |
11 Nov 1990 |
28 Jun 2022 |
09633465 |
Ruchi Jindal |
Active |
Independent Director |
20 Jun 1975 |
14 Aug 2023 |
10275445 |
Ritesh Kumar Lunkad |
Active |
NSE: SYNCOMF Board Meetings
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
|---|---|---|---|---|---|
Board Meeting Intimation |
SYNCOMF |
N/A |
INE312C01025 |
Syncom Formulations (India) Limited |
04 Nov 2024, 16:23:53 |
Financial Results/Other business matters |
SYNCOMF |
N/A |
INE312C01025 |
Syncom Formulations (India) Limited |
02 Aug 2024, 16:38:15 |
Financial Results/Other business matters |
SYNCOMF |
N/A |
INE312C01025 |
Syncom Formulations (India) Limited |
09 May 2024, 11:42:20 |
Financial Results/Other business matters |
SYNCOMF |
N/A |
INE312C01025 |
Syncom Formulations (India) Limited |
06 Feb 2024, 21:36:02 |
Financial Results/Other business matters |
SYNCOMF |
N/A |
INE312C01025 |
Syncom Formulations (India) Limited |
27 Oct 2023, 12:57:03 |
NSE: SYNCOMF Event Calendar
Purpose |
Symbol |
Industry |
ISIN |
Name |
Time |
Description |
|---|---|---|---|---|---|---|
Financial Results/Other business matters |
SYNCOMF |
- |
INE312C01025 |
Syncom Formulations (India) Limited |
04 Nov 2024, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2024 and other business matters |
Financial Results/Other business matters |
SYNCOMF |
- |
INE312C01025 |
Syncom Formulations (India) Limited |
02 Aug 2024, 00:00:00 |
To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
Financial Results/Other business matters |
SYNCOMF |
- |
INE312C01025 |
Syncom Formulations (India) Limited |
09 May 2024, 00:00:00 |
To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
Financial Results/Other business matters |
SYNCOMF |
- |
INE312C01025 |
Syncom Formulations (India) Limited |
06 Feb 2024, 00:00:00 |
To consider and approve the financial results for the period ended December 31, 2023 and other business matters |
Financial Results/Other business matters |
SYNCOMF |
- |
INE312C01025 |
Syncom Formulations (India) Limited |
27 Oct 2023, 00:00:00 |
To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
NSE: SYNCOMF Balance Sheet Data In (Cr)
| date | period_type | Ordinary Shares Number | Share Issued | Net Debt | Total Debt | Tangible Book Value | Invested Capital | Working Capital | Net Tangible Assets | Common Stock Equity | Total Capitalization | Total Equity Gross Minority Interest | Stockholders Equity | Other Equity Interest | Retained Earnings | Additional Paid In Capital | Capital Stock | Common Stock | Total Liabilities Net Minority Interest | Total Non Current Liabilities Net Minority Interest | Other Non Current Liabilities | Non Current Pension And Other Postretirement Benefit Plans | Tradeand Other Payables Non Current | Non Current Deferred Taxes Liabilities | Long Term Debt And Capital Lease Obligation | Long Term Debt | Long Term Provisions | Current Liabilities | Other Current Liabilities | Current Debt And Capital Lease Obligation | Current Debt | Current Provisions | Payables | Other Payable | Dividends Payable | Total Tax Payable | Accounts Payable | Total Assets | Total Non Current Assets | Other Non Current Assets | Non Current Prepaid Assets | Non Current Deferred Taxes Assets | Investmentin Financial Assets | Available For Sale Securities | Financial Assets Designatedas Fair Value Through Profitor Loss | Investment Properties | Goodwill And Other Intangible Assets | Other Intangible Assets | Goodwill | Net PPE | Accumulated Depreciation | Gross PPE | Construction In Progress | Other Properties | Machinery Furniture Equipment | Buildings And Improvements | Land And Improvements | Properties | Current Assets | Other Current Assets | Restricted Cash | Prepaid Assets | Inventory | Other Inventories | Finished Goods | Work In Process | Raw Materials | Other Receivables | Taxes Receivable | Accounts Receivable | Cash Cash Equivalents And Short Term Investments | Other Short Term Investments | Cash And Cash Equivalents | Cash Equivalents | Cash Financial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-30T00:00:00 | quarterly | 940,000,000.00 | 940,000,000.00 | 139,958,000.00 | 142,460,000.00 | 3,135,119,000.00 | 3,278,051,000.00 | 1,967,854,000.00 | 3,135,119,000.00 | 3,135,591,000.00 | 3,135,591,000.00 | 3,135,591,000.00 | 3,135,591,000.00 | 2,195,591,000.00 | 0.00 | 0.00 | 940,000,000.00 | 940,000,000.00 | 588,860,000.00 | 98,502,000.00 | 0.00 | 0.00 | 9,252,000.00 | 52,206,000.00 | 0.00 | 0.00 | 37,044,000.00 | 490,358,000.00 | 62,236,000.00 | 142,460,000.00 | 142,460,000.00 | 29,934,000.00 | 233,771,000.00 | 0.00 | 0.00 | 0.00 | 233,771,000.00 | 3,724,451,000.00 | 1,266,239,000.00 | 4,956,000.00 | 5,685,000.00 | 0.00 | 67,649,000.00 | 67,649,000.00 | 0.00 | 473,344,000.00 | 472,000.00 | 0.00 | 0.00 | 714,133,000.00 | 0.00 | 714,133,000.00 | 14,211,000.00 | 699,922,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2,458,212,000.00 | 116,916,000.00 | 0.00 | 34,014,000.00 | 450,531,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 54,263,000.00 | 0.00 | 882,432,000.00 | 920,056,000.00 | 917,554,000.00 | 2,502,000.00 | 0.00 | 0.00 |
| 2024-03-31T00:00:00 | quarterly | 940,000,000.00 | 940,000,000.00 | 91,926,000.00 | 724,866,000.00 | 2,880,323,000.00 | 3,606,294,000.00 | 1,682,579,000.00 | 2,880,323,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 1,941,428,000.00 | 1,046,769,000.00 | 243,802,000.00 | 940,000,000.00 | 940,000,000.00 | 1,165,211,000.00 | 99,965,000.00 | 1,219,000.00 | 33,038,000.00 | 15,941,000.00 | 49,767,000.00 | 0.00 | 0.00 | 33,038,000.00 | 1,065,246,000.00 | 5,136,000.00 | 724,866,000.00 | 724,866,000.00 | 36,309,000.00 | 243,005,000.00 | 672,000.00 | 894,000.00 | 0.00 | 241,439,000.00 | 4,046,639,000.00 | 1,298,813,000.00 | 2,056,000.00 | 5,190,000.00 | 0.00 | 34,992,000.00 | 34,992,000.00 | 0.00 | 473,344,000.00 | 1,105,000.00 | 1,105,000.00 | 0.00 | 725,115,000.00 | -626,492,000.00 | 1,351,607,000.00 | 2,056,000.00 | 92,052,000.00 | 813,778,000.00 | 440,793,000.00 | 2,928,000.00 | 0.00 | 2,747,825,000.00 | 377,000.00 | 899,000.00 | 104,240,000.00 | 210,815,000.00 | 42,636,000.00 | 76,172,000.00 | 42,919,000.00 | 49,088,000.00 | 83,708,000.00 | 47,000.00 | 1,032,984,000.00 | 1,314,755,000.00 | 681,815,000.00 | 632,940,000.00 | 630,171,000.00 | 2,769,000.00 |
| 2024-03-31T00:00:00 | annual | 940,000,000.00 | 940,000,000.00 | 91,926,000.00 | 724,866,000.00 | 2,880,323,000.00 | 3,606,294,000.00 | 1,682,579,000.00 | 2,880,323,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 2,881,428,000.00 | 1,941,428,000.00 | 1,046,769,000.00 | 243,802,000.00 | 940,000,000.00 | 940,000,000.00 | 1,165,211,000.00 | 99,965,000.00 | 1,219,000.00 | 33,038,000.00 | 15,941,000.00 | 49,767,000.00 | 0.00 | 0.00 | 33,038,000.00 | 1,065,246,000.00 | 5,136,000.00 | 724,866,000.00 | 724,866,000.00 | 36,309,000.00 | 243,005,000.00 | 672,000.00 | 894,000.00 | 0.00 | 241,439,000.00 | 4,046,639,000.00 | 1,298,813,000.00 | 2,056,000.00 | 5,190,000.00 | 0.00 | 34,992,000.00 | 34,992,000.00 | 0.00 | 473,344,000.00 | 1,105,000.00 | 1,105,000.00 | 0.00 | 725,115,000.00 | -626,492,000.00 | 1,351,607,000.00 | 2,056,000.00 | 92,052,000.00 | 813,778,000.00 | 440,793,000.00 | 2,928,000.00 | 0.00 | 2,747,825,000.00 | 377,000.00 | 899,000.00 | 104,240,000.00 | 210,815,000.00 | 42,636,000.00 | 76,172,000.00 | 42,919,000.00 | 49,088,000.00 | 83,708,000.00 | 47,000.00 | 1,032,984,000.00 | 1,314,755,000.00 | 681,815,000.00 | 632,940,000.00 | 630,171,000.00 | 2,769,000.00 |
| 2023-09-30T00:00:00 | quarterly | 940,000,000.00 | 940,000,000.00 | 799,182,000.00 | 800,895,000.00 | 2,700,246,000.00 | 3,502,601,000.00 | 667,666,000.00 | 2,700,246,000.00 | 2,701,706,000.00 | 2,701,706,000.00 | 2,701,706,000.00 | 2,701,706,000.00 | 1,761,706,000.00 | 0.00 | 0.00 | 940,000,000.00 | 940,000,000.00 | 1,335,220,000.00 | 93,722,000.00 | 0.00 | 0.00 | 16,363,000.00 | 48,355,000.00 | 0.00 | 0.00 | 29,004,000.00 | 1,241,498,000.00 | 118,349,000.00 | 800,895,000.00 | 800,895,000.00 | 30,599,000.00 | 269,971,000.00 | 0.00 | 0.00 | 0.00 | 269,971,000.00 | 4,036,926,000.00 | 2,127,762,000.00 | 7,514,000.00 | 5,175,000.00 | 0.00 | 913,613,000.00 | 913,613,000.00 | 0.00 | 473,345,000.00 | 1,460,000.00 | 0.00 | 0.00 | 726,655,000.00 | 0.00 | 726,655,000.00 | 139,000.00 | 726,516,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1,909,164,000.00 | 64,466,000.00 | 0.00 | 38,476,000.00 | 201,544,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 51,737,000.00 | 0.00 | 939,055,000.00 | 613,886,000.00 | 612,173,000.00 | 1,713,000.00 | 0.00 | 0.00 |
| 2023-03-31T00:00:00 | quarterly | 940,000,000.00 | 940,000,000.00 | 824,234,000.00 | 831,815,000.00 | 2,558,383,000.00 | 3,391,962,000.00 | 685,277,000.00 | 2,558,383,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 1,620,147,000.00 | 793,627,000.00 | 243,802,000.00 | 940,000,000.00 | 940,000,000.00 | 1,218,158,000.00 | 86,562,000.00 | 1,276,000.00 | 26,924,000.00 | 14,138,000.00 | 44,224,000.00 | 0.00 | 0.00 | 26,924,000.00 | 1,131,596,000.00 | 3,537,000.00 | 831,815,000.00 | 831,815,000.00 | 26,191,000.00 | 215,083,000.00 | 9,398,000.00 | 1,216,000.00 | 0.00 | 204,469,000.00 | 3,778,305,000.00 | 1,961,434,000.00 | 17,614,000.00 | 4,975,000.00 | 0.00 | 731,965,000.00 | 731,965,000.00 | 0.00 | 473,344,000.00 | 1,764,000.00 | 1,764,000.00 | 0.00 | 705,702,000.00 | -579,982,000.00 | 1,285,684,000.00 | 273,472,000.00 | 60,170,000.00 | 605,799,000.00 | 343,315,000.00 | 2,928,000.00 | 0.00 | 1,816,873,000.00 | 377,000.00 | 1,216,000.00 | 99,133,000.00 | 212,003,000.00 | 48,258,000.00 | 60,242,000.00 | 41,303,000.00 | 62,200,000.00 | 41,075,000.00 | 248,000.00 | 755,071,000.00 | 707,750,000.00 | 700,169,000.00 | 7,581,000.00 | 5,314,000.00 | 2,267,000.00 |
| 2023-03-31T00:00:00 | annual | 940,000,000.00 | 940,000,000.00 | 824,234,000.00 | 831,815,000.00 | 2,558,383,000.00 | 3,391,962,000.00 | 685,277,000.00 | 2,558,383,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 2,560,147,000.00 | 1,620,147,000.00 | 793,627,000.00 | 243,802,000.00 | 940,000,000.00 | 940,000,000.00 | 1,218,158,000.00 | 86,562,000.00 | 1,276,000.00 | 26,924,000.00 | 14,138,000.00 | 44,224,000.00 | 0.00 | 0.00 | 26,924,000.00 | 1,131,596,000.00 | 3,537,000.00 | 831,815,000.00 | 831,815,000.00 | 26,191,000.00 | 215,083,000.00 | 9,398,000.00 | 1,216,000.00 | 0.00 | 204,469,000.00 | 3,778,305,000.00 | 1,961,434,000.00 | 17,614,000.00 | 4,975,000.00 | 0.00 | 731,965,000.00 | 731,965,000.00 | 0.00 | 473,344,000.00 | 1,764,000.00 | 1,764,000.00 | 0.00 | 705,702,000.00 | -579,982,000.00 | 1,285,684,000.00 | 273,472,000.00 | 60,170,000.00 | 605,799,000.00 | 343,315,000.00 | 2,928,000.00 | 0.00 | 1,816,873,000.00 | 377,000.00 | 1,216,000.00 | 99,133,000.00 | 212,003,000.00 | 48,258,000.00 | 60,242,000.00 | 41,303,000.00 | 62,200,000.00 | 41,075,000.00 | 248,000.00 | 755,071,000.00 | 707,750,000.00 | 700,169,000.00 | 7,581,000.00 | 5,314,000.00 | 2,267,000.00 |
| 2022-03-31T00:00:00 | annual | 862,453,000.00 | 862,453,000.00 | 575,747,000.00 | 577,908,000.00 | 2,221,226,000.00 | 2,800,124,000.00 | 615,439,000.00 | 2,221,226,000.00 | 2,222,216,000.00 | 2,222,216,000.00 | 2,222,216,000.00 | 2,222,216,000.00 | 50,406,000.00 | 621,120,000.00 | 125,155,000.00 | 862,453,000.00 | 862,453,000.00 | 860,167,000.00 | 77,610,000.00 | 1,096,000.00 | 17,095,000.00 | 13,669,000.00 | 45,750,000.00 | 0.00 | 0.00 | 17,095,000.00 | 782,557,000.00 | 9,311,000.00 | 577,908,000.00 | 577,908,000.00 | 38,472,000.00 | 147,066,000.00 | 8,296,000.00 | 856,000.00 | 0.00 | 137,914,000.00 | 3,082,383,000.00 | 1,684,389,000.00 | 21,918,000.00 | 3,375,000.00 | 0.00 | 659,692,000.00 | 659,692,000.00 | 0.00 | 471,334,000.00 | 990,000.00 | 990,000.00 | 0.00 | 548,998,000.00 | -535,753,000.00 | 1,084,751,000.00 | 83,926,000.00 | 58,255,000.00 | 596,327,000.00 | 343,315,000.00 | 2,928,000.00 | 0.00 | 1,397,996,000.00 | 377,000.00 | 856,000.00 | 85,026,000.00 | 195,063,000.00 | 32,270,000.00 | 63,483,000.00 | 34,301,000.00 | 65,009,000.00 | 38,172,000.00 | 528,000.00 | 675,501,000.00 | 402,473,000.00 | 400,312,000.00 | 2,161,000.00 | 844,000.00 | 1,317,000.00 |
| 2021-03-31T00:00:00 | annual | 789,952,180.00 | 789,952,180.00 | 594,466,000.00 | 620,900,000.00 | 1,874,603,000.00 | 2,496,740,000.00 | 931,363,000.00 | 1,874,603,000.00 | 1,875,840,000.00 | 1,875,840,000.00 | 1,875,840,000.00 | 1,875,840,000.00 | 97,531,000.00 | 423,216,000.00 | 14,229,000.00 | 789,952,000.00 | 789,952,000.00 | 1,040,656,000.00 | 73,617,000.00 | 1,764,000.00 | 13,907,000.00 | 13,593,000.00 | 44,353,000.00 | 0.00 | 0.00 | 13,907,000.00 | 967,039,000.00 | 7,039,000.00 | 620,900,000.00 | 620,900,000.00 | 21,905,000.00 | 296,146,000.00 | 2,074,000.00 | 1,080,000.00 | 0.00 | 292,992,000.00 | 2,916,496,000.00 | 1,018,092,000.00 | 7,623,000.00 | 3,375,000.00 | 0.00 | 88,175,000.00 | 88,175,000.00 | 11,674,495.00 | 471,334,000.00 | 1,237,000.00 | 1,237,000.00 | 0.00 | 453,431,000.00 | -503,916,000.00 | 957,347,000.00 | 11,444,000.00 | 57,052,000.00 | 571,114,000.00 | 314,809,000.00 | 2,928,000.00 | 0.00 | 1,898,402,000.00 | 377,000.00 | 1,080,000.00 | 92,381,000.00 | 225,553,000.00 | 44,808,000.00 | 90,506,000.00 | 40,441,000.00 | 49,798,000.00 | 90,607,000.00 | 332,000.00 | 748,222,000.00 | 739,850,000.00 | 713,416,000.00 | 26,434,000.00 | 5,953,000.00 | 20,481,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6,331,730.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: SYNCOMF Cash Flow Data In (Cr)
| date | period_type | Free Cash Flow | Issuance Of Debt | Issuance Of Capital Stock | Capital Expenditure | End Cash Position | Other Cash Adjustment Outside Changein Cash | Beginning Cash Position | Changes In Cash | Financing Cash Flow | Net Other Financing Charges | Interest Paid Cff | Cash Dividends Paid | Common Stock Dividend Paid | Net Common Stock Issuance | Common Stock Issuance | Net Issuance Payments Of Debt | Net Short Term Debt Issuance | Net Long Term Debt Issuance | Long Term Debt Issuance | Investing Cash Flow | Net Other Investing Changes | Net Investment Purchase And Sale | Sale Of Investment | Purchase Of Investment | Net Investment Properties Purchase And Sale | Net PPE Purchase And Sale | Purchase Of PPE | Operating Cash Flow | Taxes Refund Paid | Change In Working Capital | Change In Other Current Liabilities | Change In Other Current Assets | Change In Payable | Change In Inventory | Change In Receivables | Other Non Cash Items | Depreciation And Amortization | Amortization Cash Flow | Depreciation | Pension And Employee Benefit Expense | Gain Loss On Sale Of PPE | Net Income From Continuing Operations |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | -140,947,000.00 | 0.00 | 0.00 | -81,364,000.00 | 633,834,000.00 | 0.00 | 8,797,000.00 | 625,037,000.00 | -145,576,000.00 | 6,114,000.00 | -44,741,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | -106,949,000.00 | -106,949,000.00 | -106,949,000.00 | 0.00 | 830,196,000.00 | 143,692,000.00 | 767,868,000.00 | 0.00 | 0.00 | 0.00 | -81,364,000.00 | -81,364,000.00 | -59,583,000.00 | -80,845,000.00 | -283,670,000.00 | -6,489,000.00 | -32,423,000.00 | 36,970,000.00 | 1,188,000.00 | -293,034,000.00 | -81,647,000.00 | 47,223,000.00 | 0.00 | 47,223,000.00 | 0.00 | -239,000.00 | 339,769,000.00 |
| 2023-03-31T00:00:00 | annual | -101,054,000.00 | 0.00 | 145,788,000.00 | -206,347,000.00 | 8,797,000.00 | 0.00 | 3,017,000.00 | 5,780,000.00 | 350,014,000.00 | 9,829,000.00 | -31,310,000.00 | -28,200,000.00 | -28,200,000.00 | 145,788,000.00 | 145,788,000.00 | 253,907,000.00 | 253,907,000.00 | 253,907,000.00 | 0.00 | -449,527,000.00 | 141,729,000.00 | -382,899,000.00 | 0.00 | 0.00 | -2,010,000.00 | -206,347,000.00 | -206,347,000.00 | 105,293,000.00 | -66,545,000.00 | -32,614,000.00 | 40,858,000.00 | -36,694,000.00 | 66,555,000.00 | -16,940,000.00 | -74,112,000.00 | -105,466,000.00 | 45,393,000.00 | 335,000.00 | 45,393,000.00 | -373,000.00 | 133,000.00 | 265,593,000.00 |
| 2022-03-31T00:00:00 | annual | 50,161,000.00 | 0.00 | 136,302,000.00 | -113,129,000.00 | 3,017,000.00 | 1,000.00 | 27,514,000.00 | -24,498,000.00 | 82,945,000.00 | 3,188,000.00 | -13,552,000.00 | 0.00 | 0.00 | 136,302,000.00 | 136,302,000.00 | -42,993,000.00 | -42,993,000.00 | -42,993,000.00 | 0.00 | -270,733,000.00 | 96,249,000.00 | -253,853,000.00 | 0.00 | 0.00 | 0.00 | -113,129,000.00 | -113,129,000.00 | 163,290,000.00 | -62,458,000.00 | 35,823,000.00 | -2,978,000.00 | 96,367,000.00 | -155,078,000.00 | 30,489,000.00 | 50,457,000.00 | -97,585,000.00 | 39,483,000.00 | 281,000.00 | 39,202,000.00 | -6,356,000.00 | 241,000.00 | 261,519,000.00 |
| 2021-03-31T00:00:00 | annual | -47,188,000.00 | 0.00 | 121,060,000.00 | -26,557,000.00 | 27,514,000.00 | -1,000.00 | 82,075,000.00 | -54,560,000.00 | 719,604,000.00 | 1,830,000.00 | -2,711,000.00 | 0.00 | 0.00 | 121,060,000.00 | 121,060,000.00 | 599,425,000.00 | 599,425,000.00 | 599,425,039.65 | 0.00 | -753,533,000.00 | 57,819,000.00 | -784,795,000.00 | 0.00 | 0.00 | 0.00 | -26,557,000.00 | 0.00 | -20,631,000.00 | -113,008,000.00 | -293,374,000.00 | -2,326,000.00 | -3,343,000.00 | 90,026,000.00 | -64,829,000.00 | -315,213,000.00 | -59,865,000.00 | 40,350,000.00 | 347,000.00 | 40,003,000.00 | -776,000.00 | 300,000.00 | 406,739,000.00 |
| 2020-03-31T00:00:00 | annual | 0.00 | 4,714,395.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4,714,395.00 | 0.00 | 0.00 | 0.00 | 0.00 | -69,291,500.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
NSE: SYNCOMF Income Statement Data In (Cr)
| date | period_type | Tax Effect Of Unusual Items | Tax Rate For Calcs | Normalized EBITDA | Total Unusual Items | Total Unusual Items Excluding Goodwill | Net Income From Continuing Operation Net Minority Interest | Reconciled Depreciation | Reconciled Cost Of Revenue | EBITDA | EBIT | Net Interest Income | Interest Expense | Interest Income | Normalized Income | Net Income From Continuing And Discontinued Operation | Total Expenses | Rent Expense Supplemental | Diluted Average Shares | Basic Average Shares | Diluted EPS | Basic EPS | Diluted NI Availto Com Stockholders | Net Income Common Stockholders | Otherunder Preferred Stock Dividend | Net Income | Net Income Including Noncontrolling Interests | Net Income Discontinuous Operations | Net Income Continuous Operations | Tax Provision | Pretax Income | Other Non Operating Income Expenses | Special Income Charges | Other Special Charges | Net Non Operating Interest Income Expense | Total Other Finance Cost | Interest Expense Non Operating | Interest Income Non Operating | Operating Income | Operating Expense | Other Operating Expenses | Depreciation And Amortization In Income Statement | Depreciation Income Statement | Selling General And Administration | Selling And Marketing Expense | General And Administrative Expense | Rent And Landing Fees | Gross Profit | Cost Of Revenue | Total Revenue | Operating Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-31T00:00:00 | annual | 0.19 | 0.00 | 42.30 | 0.74 | 0.74 | 25.31 | 4.72 | 165.00 | 43.03 | 38.31 | 0.80 | 4.36 | 5.52 | 24.77 | 25.31 | 234.07 | 0.70 | 94.00 | 94.00 | 0.00 | 0.00 | 25.31 | 25.31 | 0.00 | 25.31 | 25.31 | 0.00 | 25.31 | 8.64 | 33.95 | 4.90 | -0.02 | 0.02 | 0.80 | 0.36 | 4.36 | 5.52 | 25.17 | 69.07 | 3.42 | 4.72 | 4.72 | 29.46 | 27.26 | 2.20 | 0.56 | 94.24 | 165.00 | 259.24 | 259.24 |
| 2023-03-31T00:00:00 | annual | 0.04 | 0.00 | 34.12 | 0.18 | 0.18 | 20.07 | 4.54 | 149.85 | 34.30 | 29.76 | 1.32 | 3.19 | 4.72 | 19.93 | 20.07 | 206.03 | 0.97 | 92.85 | 92.85 | 0.00 | 0.00 | 20.07 | 20.07 | 0.00 | 20.07 | 20.07 | 0.00 | 20.07 | 6.50 | 26.57 | 4.52 | 0.01 | -0.01 | 1.32 | 0.21 | 3.19 | 4.72 | 16.45 | 56.18 | 2.76 | 4.54 | 4.54 | 25.03 | 23.32 | 1.71 | 0.85 | 72.64 | 149.85 | 222.49 | 222.49 |
| 2022-03-31T00:00:00 | annual | 0.01 | 0.00 | 31.91 | 0.04 | 0.04 | 19.79 | 3.95 | 146.85 | 31.95 | 28.00 | 2.00 | 1.83 | 3.93 | 19.76 | 19.79 | 200.55 | 0.95 | 87.32 | 81.69 | 0.00 | 0.00 | 19.79 | 19.79 | 0.00 | 19.79 | 19.79 | 0.00 | 19.79 | 6.39 | 26.18 | 3.66 | 0.02 | -0.02 | 2.00 | 0.10 | 1.83 | 3.93 | 17.27 | 53.70 | 2.34 | 3.95 | 3.95 | 27.45 | 26.40 | 1.05 | 0.83 | 70.97 | 146.85 | 217.82 | 217.82 |
| 2021-03-31T00:00:00 | annual | 0.04 | 0.00 | 44.80 | 0.13 | 0.13 | 29.17 | 4.04 | 167.07 | 44.93 | 40.90 | 0.87 | 0.19 | 1.35 | 29.08 | 29.17 | 204.31 | 0.82 | 80.90 | 78.08 | 0.00 | 0.00 | 29.17 | 29.17 | 0.00 | 29.17 | 29.17 | 0.00 | 29.17 | 11.53 | 40.70 | 3.79 | 0.03 | -0.03 | 0.87 | 0.28 | 0.19 | 1.35 | 35.01 | 37.24 | 1.66 | 4.03 | 4.03 | 17.72 | 16.90 | 0.82 | 0.73 | 72.24 | 167.07 | 239.32 | 239.32 |
FII & DII Data (In Cr)
| Date | FII Gross Purchase | FII Gross Sales | FII Net Purchase / Sales | DII Gross Purchase | DII Gross Sales | DII Net Purchase / Sales |
|---|---|---|---|---|---|---|
| 2025-02-03 | 12,505.92 | 16,464.29 | -3,958.37 | 19,319.48 | 16,611.25 | 2,708.23 |
| 2025-01-30 | 10,513.63 | 15,096.58 | -4,582.95 | 13,934.35 | 11,768.46 | 2,165.89 |
| 2025-01-29 | 7,644.40 | 10,230.83 | -2,586.43 | 12,871.38 | 11,078.67 | 1,792.71 |
| 2025-01-27 | 9,488.57 | 14,504.03 | -5,015.46 | 16,503.43 | 9,861.28 | 6,642.15 |
| 2025-01-24 | 11,230.47 | 13,988.96 | -2,758.49 | 12,835.41 | 10,433.10 | 2,402.31 |
| 2025-01-23 | 13,316.55 | 18,779.07 | -5,462.52 | 14,412.73 | 10,700.18 | 3,712.55 |
| 2025-01-22 | 12,936.64 | 16,962.89 | -4,026.25 | 15,437.18 | 11,796.96 | 3,640.22 |
Piotroski F-Score
5/9
0
1
2
3
4
5
6
7
8
9
Key Metrics
EPS
0.39
P/E
52.692307
P/B
4.550487
Dividend Yield
N/A
Market Cap
1,931.70 Cr.
Face Value
4.516
Book Value
4.516
ROE
10.08%
EBITDA Growth
38.76 Cr.
Debt/Equity
4.543
Short Term
Subscribe to unlock this feature
Medium Term
Subscribe to unlock this feature
Long Term
Subscribe to unlock this feature
Yearly Stock Performance Heatmap
Latest Updates
Ashoka Buildcon Arm Signs Rs 1,391 Crore Pact With NHAI
Ashoka Buildcon Ltd. announced on Monday, via an exchange filing, that its wholly owned subsidiary, Ashoka Bowaichandi Guskara Road Pvt Ltd., has exec...
Budget 2025: Rahul Bajoria On Addressing Income Growth And Consumption Trends
"However, discretionary, high-value consumption is taking a step back due to income growth settling at high single digits." Over the past fe...
FPIs Stay Net Sellers, Sell Stocks Worth Rs 2,575 Crore
Foreign portfolio investors stayed net sellers for the second straight session on Monday and sold stocks worth approximately Rs 2,575.1 crore, accordi...
Budget 2025: AMFI Seeks Tax Policy Reforms To Drive Mutual Fund Investments In 15-Point Proposal
The Association of Mutual Funds of India on Monday released a 15-point proposal for Union Budget 2025-26 requesting changes in tax policies that are i...
Apple iPhone SE 4: Price To Features, 11 Things You Need To Know
iPhone 16e (Not iPhone SE 4): If recent reports are to be believed, Apple may discontinue the SE label and rename iPhone SE 4 as iPhone 16e. Most Affo...
Rupee Closed Weaker Against The US Dollar
The rupee weakened by five paise to close at 85.83 against the US dollar. The Indian rupee had declined to a fresh low against the US dollar during th...
Table Space Founder Amit Banerji Dies Of Heart Attack At Age Of 45
Amit Banerji, the founder, chairman and chief executive officer of managed workspace provider Table Space, died after suffering from a heart attack, r...
War Fatigue, Economic Breakdown Or Pro-West? Why Syria's Al-Sharaa Is Seen Soft On Israel
The strategic positions have been used by Israeli forces to carry out hundreds of strikes to destroy Syria's military infrastructure. In 2011, be...
Popular Questions
What is the Market Cap of syncomf?
The market capitalization of Syncom Formulations (India) Limited is ₹1,932 Cr as of 05 Feb 2025.
What are the PE and PB ratios of Syncom Formulations (India) Limited?
The PE and PB ratios of Syncom Formulations (India) Limited are Not Available and 4.550487 respectively as of 05 Feb 2025.
What is the 52 Week High of Syncom Formulations (India) Limited?
The 52-week high of Syncom Formulations (India) Limited is ₹27.9 as of 05 Feb 2025.
What is the 52 Week Low of Syncom Formulations (India) Limited?
The 52-week low of Syncom Formulations (India) Limited is ₹10.95 as of 05 Feb 2025.
What are the earnings per share (EPS) for Syncom Formulations (India) Limited?
The Earnings Per Share (EPS) of Syncom Formulations (India) Limited is ₹0.39 as per the most recent quarterly results available on Fincept.
What is the ROE (Return on Equity) of Syncom Formulations (India) Limited?
The Return on Equity (ROE) of Syncom Formulations (India) Limited is 10.08% as per the most recent financial year data. Explore more on Fincept.